此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Videocapillaroscopic Findings in Hand Osteoarthritis

2026年11月11日 更新者:Nurten NAS KIRDAR、Bandırma Onyedi Eylül University

Association of Nailfold Videocapillaroscopy Findings With Clinical, Functional, and Radiological Characteristics in Primary Hand Osteoarthritis: A Comparative Cross-Sectional Study With Healthy Controls

The purpose of this study is to compare microvascular changes-assessed via nailfold videocapillaroscopy-in patients with primary hand osteoarthritis against a healthy control group, and to investigate the relationship between capillaroscopic findings and disease severity, functional status, and clinical characteristics.

研究概览

地位

尚未招聘

详细说明

In this context, the associations between capillaroscopic parameters and the Kellgren-Lawrence radiological grading, handgrip strength, the Functional Index for Hand Osteoarthritis (FIHOA), and the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores will be evaluated. Furthermore, the study aims to determine the potential clinical value of nailfold videocapillaroscopy in identifying microvascular alterations associated with primary hand osteoarthritis.

研究类型

观察性的

注册 (估计的)

130

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

研究联系人备份

  • 姓名:Ayşegül ÖZDOĞAN BİRCAN, Specialist Physician

学习地点

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

概率样本

研究人群

The study population will consist of patients diagnosed with primary hand osteoarthritis and age- and sex-matched healthy controls. Participants will undergo clinical assessment, hand function evaluation, radiographic assessment, and nailfold videocapillaroscopy.

描述

Inclusion Criteria:

  • Patient group (Primary hand osteoarthritis)

    • Being 18 years of age or older.
    • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
    • Being willing to participate in the study and having signed the written Informed Consent Form.
    • Being able to undergo clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
    • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.

Healthy control group

  • Being 18 years of age or older.
  • Having no diagnosis of inflammatory rheumatologic disease or primary hand osteoarthritis.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being similar to the patient group in terms of age and gender.
  • Being able to undergo nailfold videocapillaroscopy assessment.

Exclusion Criteria:

  • Patient group

    • Being under 18 years of age.
    • Diagnosis of secondary osteoarthritis of the hand (due to trauma, infection, metabolic, or other causes).
    • Presence of rheumatoid arthritis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, Sjögren's syndrome, inflammatory myopathies, vasculitis, or other connective tissue diseases.
    • History of Raynaud's phenomenon.
    • History of malignancy.
    • Chronic renal failure (stage 4-5) or advanced liver failure.
    • Active infection or a serious infection within the last four weeks.
    • Pregnancy or breastfeeding.
    • History of a neurological condition that could affect hand grip strength (e.g., hemiplegia, tetraplegia, peripheral nerve injury, or other neurological/neuromuscular disorders resulting in loss of muscle strength).
    • History of trauma, surgical intervention, or any procedure affecting the nail bed of the fingers within the last month.
    • Presence of an open wound, active infection, severe dermatological condition, or deformity that would hinder the assessment of the nail fold.
    • Refusal to participate in the study or failure to sign the informed consent form.

Healthy control group

In addition to the exclusion criteria listed above:

  • Diagnosis of primary osteoarthritis of the hand or any inflammatory rheumatic disease.
  • Presence of hand pain or any chronic musculoskeletal disorder that affects hand function.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:CASE_CONTROL
  • 时间观点:CROSS_SECTIONAL

队列和干预

团体/队列
hand osteoarthritis group

hand osteoarthritis group;

  • Being 18 years of age or older.
  • Having a diagnosis of primary hand osteoarthritis in accordance with the 2018 EULAR recommendations.
  • Being willing to participate in the study and having signed the written Informed Consent Form.
  • Being capable of undergoing clinical assessment, nailfold videocapillaroscopy, and the necessary functional evaluations.
  • Having hand radiographs of sufficient quality to be evaluated according to the Kellgren-Lawrence classification system.
control group

control group;

  • Being 18 years of age or older.
  • Absence of a diagnosis of inflammatory rheumatic disease or primary osteoarthritis of the hand.
  • Willingness to participate in the study and having signed the written Informed Consent Form.
  • Having characteristics similar to the patient group in terms of age and gender.
  • Being able to undergo the nailfold videocapillaroscopy assessment.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Nailfold videocapillaroscopic microvascular parameters
大体时间:6 months

The primary outcome is the comparison of nailfold videocapillaroscopic microvascular parameters between patients with primary hand osteoarthritis and healthy controls.

Nailfold videocapillaroscopy will be performed using the Dino-Lite Capillary Scope Pro200 digital microscope and DinoCapture v2.0 software. Prior to the examination, participants will be required to rest for at least 15 minutes in a room maintained at a constant temperature of 20-22°C; they will also be instructed to refrain from smoking or consuming caffeine for at least 30 minutes before the procedure. Participants will be questioned regarding any recent manicures, nail-biting, local trauma, or other procedures that might affect the nail bed. During the examination, the hands will be kept at the level of the heart, and immersion oil will be applied to the nailfold. The second through fifth digits of both hands will be evaluated at ×200 magnification, and images of two 1 mm areas from each digit will be recorded.

6 months

次要结果测量

结果测量
措施说明
大体时间
Kellgren-Lawrence classification
大体时间:6 months

Participants' hand radiographs will be evaluated for signs of osteoarthritis. The presence of osteophytes, joint space narrowing, subchondral sclerosis, cystic changes, and deformities in the distal interphalangeal, proximal interphalangeal, and first carpometacarpal joints will be recorded. The radiological severity of the disease will be graded from 0 to 4 for each joint using the Kellgren-Lawrence classification: grade 0, no radiological evidence of osteoarthritis; grade 1, questionable joint space narrowing and possible osteophytes; grade 2, definite osteophytes and possible joint space narrowing; grade 3, multiple osteophytes, definite joint space narrowing, sclerosis, and possible bone contour deformity; and grade 4, severe joint space loss, large osteophytes, marked sclerosis, and bone deformity. Radiographic hand osteoarthritis will be defined, in general, as a Kellgren-Lawrence grade of ≥2.

6 months
Australian/Canadian Osteoarthritis Hand Index (AUSCAN)
大体时间:6 months

Disease-related pain, stiffness, and functional impairment will be assessed using the Australian/Canadian Osteoarthritis Hand Index (AUSCAN). AUSCAN is a 15-item, patient-reported outcome measure developed for hand osteoarthritis, comprising subscales for pain (5 items), morning stiffness (1 item), and physical function (9 items). The function subscale evaluates difficulty with activities of daily living, such as turning on a faucet, operating a doorknob, buttoning clothes, opening a jar, carrying heavy objects, and grasping small items. The scale can be administered using Likert, visual analog, or numerical rating formats; the specific version and scoring method to be used in this study will be standardized in advance. Higher scores indicate more severe symptoms and greater loss of function.

6 months
Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index)
大体时间:6 months

Functional impairment due to hand osteoarthritis will also be assessed using the Functional Index for Hand Osteoarthritis (FIHOA/Dreiser Index). The FIHOA is a 10-item scale that evaluates daily hand functions, such as using a key, cutting with a knife, opening a bottle or jar, buttoning, writing, lifting objects, and shaking hands. Each item is scored on a scale of 0-3, with a total score ranging from 0-30; a higher score indicates greater functional impairment. The validity and reliability of the Turkish version of the FIHOA have been established, and it has been reported to demonstrate high internal consistency and test-retest reliability.

6 months
Handgrip strength
大体时间:6 months

Grip strength will be measured separately for each hand using a standard hand dynamometer (Baseline brand, 200 lb LITE hydraulic hand dynamometer). During the measurement, the participant will be in a seated position, with the shoulder in adduction and neutral rotation, the elbow flexed at approximately 90°, the forearm in a neutral position, and the wrist in slight extension. Three measurements will be taken for each hand, with short rest intervals between them; the analysis will utilize either the mean of these measurements or the highest value, in accordance with a pre-established protocol. The brand and model of the dynamometer used will be specified in the research form. Grip strength measurements obtained via a hand dynamometer have been shown to be reliable in patients with hand osteoarthritis.

6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Nurten NAS KIRDAR、Bandırma Onyedi Eylül University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月20日

初级完成 (估计的)

2027年4月20日

研究完成 (估计的)

2027年4月30日

研究注册日期

首次提交

2026年11月11日

首先提交符合 QC 标准的

2026年11月11日

首次发布 (实际的)

2026年11月17日

研究记录更新

最后更新发布 (实际的)

2026年11月17日

上次提交的符合 QC 标准的更新

2026年11月11日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他研究编号

  • E-67961857-050.04-2600065387

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data (IPD) will not be shared with other researchers due to patient confidentiality and data privacy considerations. Only anonymized aggregate data may be reported in the publication.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅